Medication info
Terahiptin Duo Sustained Release Tablet 10/750 mg

Terahiptin Duo Sustained Release Tablet 10/750 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Farmgen Science Co., Ltd.
Appearance
Yellow, egg-shaped, sustained-release, film-coated tablets
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202201427 · Approved 2022.04.04 · Insurance code 670105300

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Ingredients

Manufacturer
Farmgen Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is administered to improve blood sugar control in patients with type 2 diabetes using a combination of teneligliptin and metformin, as an aid to diet and exercise therapy. It helps effectively manage blood sugar levels and alleviates symptoms of diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored, and the dose should be adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering medicines. Since this may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole without splitting, crushing, grinding, or chewing it.

Precautions

This medication is a diabetes treatment that aids in blood sugar control and should not be used by patients with impaired kidney function. It is contraindicated in patients with severe kidney disease, heart failure, or liver dysfunction. It should be temporarily discontinued before and after surgery or during severe infections or traumatic conditions and can be resumed only after kidney function has stabilized. It is safest not to use this medication during pregnancy or in women who may become pregnant. The risk of hypoglycemia may increase when used with other diabetes medications, so patients should be well-informed about hypoglycemia symptoms and management. There is a rare risk of lactic acidosis, which occurs when there is an excessive accumulation of lactic acid in the body leading to a dangerous condition, symptoms include fatigue, muscle pain, difficulty breathing, and abdominal pain. Patients experiencing these symptoms should contact their doctor immediately, especially those with impaired kidney or liver function as the risk of lactic acidosis is higher. Alcohol consumption may increase the risk of lactic acidosis, so it is advised to avoid drinking while taking this medication. This medication may lower vitamin B12 levels, and regular blood testing is recommended. Elderly patients may have reduced kidney function necessitating dose adjustments and regular monitoring of kidney function. Some patients may experience side effects such as dyspepsia, diarrhea, constipation, headache, dizziness, fatigue, itching, rash, allergic dermatitis, arthralgia, malaise, allergic rhinitis, elevated serum uric acid, peripheral edema, stomatitis, gastric polyps, colonic polyps, duodenal ulcer, gastroesophageal reflux disease, decreased appetite, increased amylase, elevated lipase, and increased AST (GOT), ALT (GPT), GGT, ALP, or proteinuria. Serious adverse reactions such as acute pancreatitis or interstitial pneumonia have been reported rarely, and any persistent abdominal pain, difficulty breathing, or fever should prompt immediate medical consultation. If sudden skin rash or blisters occur during this treatment, patients should consult their physician promptly. Additionally, as this medication may cause allergic reactions to certain coloring agents, care should be taken in patients with a history of allergies. This medication can interact with other drugs; therefore, it is important to inform your doctor or pharmacist of any other medicines being taken. Particularly when used in combination with medications that may affect kidney function, close monitoring of kidney function is necessary. Lastly, this medication is not recommended for children as its safety and efficacy have not been established.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • atypical dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
Show 194 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • increased GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • myasthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • visual impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood glucose abnormalities
  • increased blood glucose
  • increased blood pressure
  • hepatic coma
  • lumbar spinal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral stones
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory abnormalities
  • headache
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal stenosis
  • tendonitis
  • neck pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • herpes zoster
  • upper respiratory infection
  • gastroenteritis
  • pneumonia
  • H1N1 influenza
  • bronchitis
  • chronic sinusitis
  • folliculitis
  • cystitis
  • soft tissue infection
  • urinary tract infection
  • pharyngitis
  • streptococcal infection
  • tinea pedis
  • subcutaneous abscess
  • Helicobacter gastritis
  • vomiting
  • chronic gastritis
  • upper abdominal pain
  • dysentery
  • esophagitis
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal discomfort
  • hypercholesterolemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • iliac artery stenosis
  • bleeding
  • increased blood glucose
  • abnormal sputum
  • liver biopsy
  • decreased neutrophil count
  • blood glucose abnormalities
  • increased blood pressure
  • increased serum creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • insomnia
  • pressure sore ulcer
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • falls
  • animal bites
  • radial fracture
  • breast cancer
  • uterine abscess
  • hearing loss
  • endolymphatic hydrops
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow, egg-shaped, sustained-release, film-coated tablets

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.